IP Library › Granted Patent US 9,468,704
Granted Patent B2
US 9,468,704 · App. 13/665,307 · Granted Oct 18, 2016

Implant made of a biodegradable magnesium alloy

Inventor: Bodo Gerold (Zellingen, DE)
Assignee: BIOTRONIK VI PATENT AG
A61L31/022A61L31/148C22C23/06C22F1/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,468,704
App. No.
13/665,307
Granted
Oct 18, 2016
Kind
B2
Abstract

An implant made in total or in parts of a biodegradable magnesium alloy consisting of Y: 2.0-6.0% by weight, Nd: 1.5-4.5% by weight, Gd: 0-4.0% by weight, Dy: 0-4.0% by weight, Er: 0-4.0% by weight, Zr: 0.1-1.0% by weight, Li: 0-0.2% by weight, Al: 0-0.3% by weight, under the condition that a) a total content of Er, Gd and Dy is in the range of 0.5-4.0% by weight and b) a total content of Nd, Er, Gd and Dy is in the range of 2.0-5.5% by weight, the balance being magnesium and incidental impurities up to a total of 0.3% by weight.

Claims (38)

1. A vascular implant made in total or in parts of a biodegradable magnesium alloy consisting essentially of:

Y: 2.0-6.0% by weight,

Nd: 1.5-4.5% by weight,

Gd: 0-4.0% by weight,

Dy: 0-4.0% by weight,

Er: 0-4.0% by weight,

Zr: 0.1-1.0% by weight,

Li: 0-0.2% by weight,

Al: 0-0.3% by weight;

under the condition that:

a) a total content of Er, Gd and Dy is in the range of 0.5-4.0% by weight, and

b) a total content of Nd, Er, Gd and Dy is in the range of 2.0-5.5% by weight;

the balance being magnesium and incidental impurities up to a total of 0.3% by weight.

2. The vascular implant of claim 1 , wherein the content of Y is 3.5-4.5% by weight.

3. The vascular implant of claim 2 , wherein the content of Y is 3.9-4.1% by weight.

4. The vascular implant of claim 1 , wherein the content of Nd is 1.5-3.0% by weight.

5. The vascular implant of claim 1 , wherein the content of Nd is 2.0-3.0% by weight.

6. The vascular implant of claim 1 , wherein the content of Zr is 0.1-0.7% by weight.

7. The vascular implant of claim 1 , wherein the total content of Er, Gd and Dy is in the range of 0.5-1.5% by weight.

8. The vascular implant of claim 1 , wherein the total content of Nd, Er, Gd and Dy is in the range of 2.0-3.5% by weight.

9. The vascular implant of claim 1 , wherein the area percentage of particles in the alloy having an average particle size in the range of 1 to 15 μm is less than 3%.

10. The vascular implant of claim 1 , wherein the implant is a stent.

11. A method of manufacturing a vascular implant, comprising:

providing a biodegradable magnesium alloy consisting essentially of:

Y: 2.0-6.0% by weight,

Nd: 1.5-4.5% by weight,

Gd: 0-4.0% by weight,

Dy: 0-4.0% by weight,

Er: 0-4.0% by weight,

Zr: 0.1-1.0% by weight,

Li: 0-0.2% by weight,

Al: 0-0.3% by weight;

under the condition that:

a) a total content of Er, Gd and Dy is in the range of 0.5-4.0% by weight, and

b) a total content of Nd, Er, Gd and Dy is in the range of 2.0-5.5% by weight;

the balance being magnesium and incidental impurities up to a total of 0.3% by weight; and

forming a vascular implant from the alloy.

12. The method of claim 11 , wherein the vascular implant is a stent.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: BIOTRONIK VI PATENT AG
To: BIOTRONIK AG
Reel/Frame 045853/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2012
From: GEROLD, BODO
To: BIOTRONIK VI PATENT AG
Reel/Frame 029411/0441 →
Priority Claims (2)
DE 10 2004 043 232 · Sep 7, 2004 · national
EP 08165463 · Sep 30, 2008 · regional
Continuity (3)
Continuation In Part 12566312 · Sep 24, 2009
Continuation In Part 11221344 · Sep 7, 2005
Related Publication 20130060326A1 · Mar 7, 2013